PMC Issues White Paper to Help FDA Update Outdated Rx/Dx Co-development Concept Paper | GenomeWeb

NEW YORK (GenomeWeb News) – The Personalized Medicine Coalition today released a white paper outlining areas requiring more clarity from the US Food and Drug Administration on facilitating the development and regulatory review of drugs and companion tests to determine dosing, predict benefit, or gauge adverse reactions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.